Researchers assessed wait times at a single center for patients with juvenile idiopathic arthritis and described factors associated with longer wait times.
PPI use in children is associated with a small but significant increased risk for any fracture.
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
Researchers addressed the genetic association between juvenile idiopathic arthritis-associated uveitis and idiopathic pediatric uveitis.
Researchers assessed protective antibody responses to diphtheria and tetanus vaccination in patients with polyarticular-course juvenile idiopathic arthritis.
Drug reaction with eosinophilia and systemic symptoms (DReSS) with exposure to interleukin-1 or interleukin-6 inhibition may be linked to high fatality lung disease in systemic juvenile idiopathic arthritis.
A protein epitope targeted by the antibody response in children with Kawasaki disease has been identified.
Dr. Reddy’s Laboratories announced the launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, the generic equivalent to Vimovo®.
The European League Against Rheumatism developed recommendations for the collection, analysis, and use of big data in rheumatic and musculoskeletal disorders.
Researchers collected retrospective data from patients with rheumatic diseases who received live attenuated booster doses of measles-mumps-rubella or measles-mumps-rubella varicella during treatment with immunosuppressive therapy.